Summary
This 2023 consensus clinical practice guideline from the American Heart Association, American College of Cardiology, and allied professional organisations provides evidence-based recommendations for the management of chronic coronary disease in United States populations. The guideline addresses risk assessment, diagnostic evaluation, and therapeutic strategies. Though primarily a clinical cardiology guideline with limited direct relevance to agricultural or soil health research, it may incorporate dietary and lifestyle modification recommendations typical of coronary disease prevention frameworks.
Regional applicability
This is a United States-authored clinical guideline. Its direct applicability to United Kingdom cardiovascular practice may be limited, as the UK follows NICE and British Cardiovascular Society guidance adapted to NHS contexts; however, underlying evidence base and therapeutic principles are likely to have international relevance to coronary disease management.
Key measures
Clinical management protocols, risk assessment frameworks, diagnostic criteria, therapeutic recommendations
Outcomes reported
The guideline synthesises evidence-based recommendations for comprehensive management of chronic coronary disease, including patient risk assessment, diagnostic evaluation, and therapeutic strategies.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.